Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCRATCH Pilot Study: Safety of Chemoradiation Plus Cetuximab in Stage III NSCLC
2005-000329-52Phase 4Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Apr 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of cetuximab in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Guy's and St Thomas' NHS Foundation Trust. Started Apr 2005; status: completed.
02
Drugs
cetuximab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2005-000329-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000329-52.